261 related articles for article (PubMed ID: 21896306)
1. Imaging biomarkers in Parkinson's disease.
Brooks DJ; Pavese N
Prog Neurobiol; 2011 Dec; 95(4):614-28. PubMed ID: 21896306
[TBL] [Abstract][Full Text] [Related]
2. Imaging in Parkinson's disease: the role of monoamines in behavior.
Brooks DJ; Piccini P
Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: diagnosis.
Brooks DJ
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S31-3. PubMed ID: 22166447
[TBL] [Abstract][Full Text] [Related]
5. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
7. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
8. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Thobois S; Guillouet S; Broussolle E
Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
[TBL] [Abstract][Full Text] [Related]
9. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
Meles SK; Oertel WH; Leenders KL
Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
11. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
12. Imaging approaches to Parkinson disease.
Brooks DJ
J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
[TBL] [Abstract][Full Text] [Related]
13. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
Jellinger KA
J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
[TBL] [Abstract][Full Text] [Related]
14. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Saeed U; Lang AE; Masellis M
Front Neurol; 2020; 11():572976. PubMed ID: 33178113
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
Nikolaus S; Antke C; Müller HW
Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
[TBL] [Abstract][Full Text] [Related]
17. Imaging in Parkinson's Disease.
Politis M; Pagano G; Niccolini F
Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
[TBL] [Abstract][Full Text] [Related]
18. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
Noyce AJ; Dickson J; Rees RN; Bestwick JP; Isaias IU; Politis M; Giovannoni G; Warner TT; Lees AJ; Schrag A
Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging of Parkinson's disease: Expanding views.
Weingarten CP; Sundman MH; Hickey P; Chen NK
Neurosci Biobehav Rev; 2015 Dec; 59():16-52. PubMed ID: 26409344
[TBL] [Abstract][Full Text] [Related]
20. Transcranial sonography in relation to SPECT and MIBG.
Kajimoto Y; Miwa H; Kondo T
Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]